![中国首款自研P-CAB替戈拉生片获批 罗欣药业“创仿结合”战略迎新里程碑](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
5月11日会议录像
5月12日会议录像
会议议程:
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
讨论议题
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
5月11日会议简报
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
5月12日会议简报
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![【会议录像】5.11-5.12日,FDA关于儿科肿瘤药物的ODAC会议(附:会议材料)](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![中国首款自研P-CAB替戈拉生片获批 罗欣药业“创仿结合”战略迎新里程碑](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
点击这里,帮您找到理想的合作伙伴!
本篇文章来源于微信公众号:药时代
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权
5月11日会议录像
5月12日会议录像
点击这里,帮您找到理想的合作伙伴!
本篇文章来源于微信公众号:药时代
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权